​​

Open Access

What is Open Access?

Open access (OA) is the practice of providing unrestricted access via the Internet to peer-reviewed scholarly research. Open access journals provide 'gold' open access, meaning immediate open access to all of their articles on the publisher's website. 'Gold' open access for individual articles is funded by authors, institutions, funders, or sponsors who pay an open access article-processing charge (APC) after acceptance.

What types of articles will HemaSphere publish?

HemaSphere publishes Original Research, Reviews, Guidelines, and shorter articles including case reports, letter to the editor and editorials as well as EHA material called HemaTopics. To enhance quality, readability and to be more competitive with other leading scientific journals, all manuscripts must conform to word-count standards for article length, references, and limited number of figure pieces. Please visit the Instructions for Authors for more information.

How will readers know articles are open access?

All open access articles will be marked with an icon bearing 'Open' on the full-text and PDF formats of the published work, and information on the type of creative commons license will be available on all article formats and listed in the article metadata.

Who retains copyright of the open access articles?

Authors retain copyright of their content. Open access articles will be freely available to read, download and share from the time of publication. HemaSphere publishes articles under the Creative Commons Attribution Non-Commercial Non Derivative 4.0 license. If your research is funded by one of the following parties who requires a CCBY license, you may opt for the Creative Commons Attribution CC-BY 4.0 license.

  • National Institutes of Health Research (NIHR)
  • Bill and Melinda Gates Foundation
  • Charity Open Access Fund (COAF)
  • Department of Health (DH)
  • International Development Research Centre
  • Research Councils UK (RCUK) 
  • Wellcome Trust 
  • Austrian Science Fund (FWF)
  • Swedish Research Council
  • World Health Organization (WHO)
  • World Bank
  • Worldwide Cancer Research
  • Yorkshire Cancer Research

Attribution-NonCommercial-NoDerivs: CC BY-NC-ND

This license is the most restrictive of the six main licenses, only allowing others to download your works and share it with others as long as they credit you, but they can't change the work in any way or use it commercially.

Attribution: CC-BY

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered.

If I publish in HemaSphere, does this make me compliant with my funding body requirements?

HemaSphere's services and policies ensure that authors can fully comply with the public access requirements of major funding bodies worldwide.

Is HemaSphere online only?

Yes, HemaSphere is available online, with no print edition.

How do I subscribe to HemaSphere?

HemaSphere is an open access journal, so no subscription is needed to read it.

Does HemaSphere have an impact factor? Is HemaSphere indexed in PubMed Central or Medline?

As a brand-new journal, HemaSphere does not yet have an Impact Factor and is not yet included in PubMed Central or Medline. As soon as the required application criteria are met, the journal will apply for indexing in these databases. When accepted, indexing will occur retroactively. Similarly, when application criteria are met, HemaSphere will apply for an Impact Factor.

Does HemaSphere have clear editorial and ethical policies?

Yes, HemaSphere is a member of the Committee of Publication Ethics and adheres to their guidelines. More details on HemaSphere’s editorial and ethical policies can be found in the Instructions for Authors.